• Welcome

    Welcome to DoubleInStocks.com your destination for stock alerts, stock news and more covering the exciting NASDAQ, NYSE, AMEX, OTC and other exchanges. Our members receive stock alerts via email so don't forget to sign up below. It's easy and FREE.



 
 
  • Advertise

 
 
 
 
 
 
 
 
Sign up

For Our 100% Free Stock Alerts!


PROT, MSLP - Stem Cell IR & MusclePharm Achieves Certification Stock Update!
By : The Editor , Mon, 06 Sep 2010

money 1
signup3m

__

http://doubleinstocks.com/img/prot_logo_225x70.jpg

Investor Information

PROTEONOMIX, INC. (OTC.BB: PROT) is a biotechnology company engaged in the discovery and development of stem cell therapeutic and cosmeceutical products. We are developing pre clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. Our discoveries involve non embryonic stem cell treatments.

We have developed sufficient technology for patent applications including a medium and a scaffolding for enhancing the growth of stem cells, a growth platform for stem cells, a unique cord blood banking cryopreservation bag and cosmetic products utilizing a secreted matrix derived from stem cells. We have developed some of our intellectual property utilizing our management and advisory team in conjunction with third party universities and research centers.

We have concentrated on our cosmeceutical treatments based on our licensed technology which we believe will be our lead revenue product in the market. We have completed the development of our cosmeceutical products and we anticipate sales to begin in 2010.

Proteonomix, Inc. (PROT) Plans European Investor Road Show

-Michael Cohen, Chairman and CEO, to Visit Several European Cities to Discuss Company’s Growth Plan and Future Outlook With Investors

PROTEONOMIX, INC. (OTC.BB:PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced last week that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.

Scheduled for early October, Mr. Cohen will discuss with sophisticated investors the recent contract to establish a joint venture with a group of investors that will establish a new stem cell treatment and research facility in the United Arab Emirates (U.A.E.). In addition, Mr. Cohen will discuss the opportunity to set up additional joint ventures in other countries using the U.A.E. arrangement as a model.

The recent contract calls for the joint venture partner to invest $5 million on or before September 10, 2010 in a Joint Venture company, XGEN Medical LLC. (”XGen”), a Nevis Island limited liability company.

For additional details about the joint venture agreement, please refer to the August 17, 2010 press release.

Proteonomix has made great strides recently,” stated Mr. Cohen, “and we have been contacted by several European entities that have requested additional information about our proprietary stem cell activities. In recognition of the interest in Europe and the potential for additional joint venture agreements in various European countries, we recognize that it is propitious to meet with a number of the European institutional investors both to educate them on the intrinsic value of Proteonomix shares and garner interest in strategic relationships.”

http://doubleinstocks.com/img/prot_chart_aug17_2010.png

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.’s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD).

http://www.proteonomix.com/

__

mslp_logo_171x112

MusclePharm Announces MuscleGel Achieves NSF Certification

MusclePharm® Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, today announced MuscleGel achieves NSF certification. In addition, the Company’s Recon and Assault nutritional products will be NSF certified within the coming months.

“We are extremely pleased MusclePharm’s MuscleGel is now NSF certified and look forward to Recon and Assault’s future addition to the NSF’s list of approved supplements,” commented Brad Pyatt, MusclePharm’s Chief Executive Officer. “Our Chief Medical Researcher, Dr. Jeffery Stout, Ph.D. and his team of scientists, doctors, and top professional athletes were instrumental in achieving the NSF’s certification of MuscleGel, Recon and Assault. These three products provide strong, unique opportunities for us to expand MusclePharm’s distribution within the professional athletic community, including the MLB and NFL.”

NSF International is an independent, not-for-profit organization that meets the growing demands of athletes, coaches and all those concerned about banned substances in sports supplements. NSF International created the new NSF Certified for Sport™ Program. This new NSF program is a focused solution designed to minimize the risk that a dietary supplement or sports nutrition product contains banned substances. This program is part of NSF’s successful 60-year history of providing certification programs for food, water and consumer goods.

MLB, the MLB Player’s Association, NFL, the NFL Player’s Association, PGA, LPGA and the CCES have all chosen NSF’s Certified for Sport™ program to help verify the products their athletes use are safer and free of banned substances. NSF GMP for Sport™ certification verifies that the facility, operations and ingredient sourcing are in compliance with GMP requirements via ongoing audits.

MusclePharm products are currently available in 1,200 of the top General Nutrition Centers (GNC) in the United States, as well as Vitamin Shop. MusclePharm’s award-winning products — Assault®, Battle Fuel®, Bullet Proof®, Combat Powder®, Recon® and Shred Matrix®—are also available online at gnc.com, bodybuilding.com, amazon.com and many other locations.

http://doubleinstocks.com/img/mslp_bottles_227x180.gif

MusclePharm’s top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside™. Headquartered in Aurora, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances and tested by athletes.

They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists.

www.musclepharm.com

__

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations.Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB). Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading share from a third party (Swiss Financial Report)  for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB).

____________________

Sign Up for our FREE Daily Stock Newsletter

____________________

http://doubleinstocks.com/img/doubleinstocks_buscard.jpg

ctse16

DoubleInStocks would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com



 
Share/Bookmark
 

Tags:

|   |   |   |   |   |   |   |   |  
 
 
 

 

  • Exclusive Videos













  • Hot stocks to watch!

    Research In Motion Ltd - RIMM

    Home Depot - HD

    Direxion Shs Etf Tr - TZA

    Urban Outfitters Inc - URBN

    Cleantech Transit, Inc. - CLNO.OB

    Bucyrus International Inc - BUCY

    Advanced Micro Devices - AMD

    Citigroup Inc - C

    iShares Down Jones U.S. Real Estate Index - IYR

    iShares Silver Trust ETF - SLV

    Weatherford Internation Lt - WFT

    Nokia Corp - NOK

    Dell Inc - DELL

    Dynegy Inc Del - DYN

    Crown Equity Holdings Inc. - CRWE.OB

    Baidu Inc - BIDU

    Apple Inc - AAPL

    Exxon Mobil Corp - XOM

    JA Solar Holdings Co Ltd - JASO

    Corning Inc - GLW

    Sterling Financial Corp Wa - STSA

    Starbucks Corp - SBUX